Ant Uzay
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Genetics top 10%
Papers in
- Hematology 10
- Hematopoietic Stem Cell Transplantation 5
- Chronic Myeloid Leukemia Treatments 5
- Platelet Disorders and Treatments 2
-
- Lymphoma Diagnosis and Treatment 5
- Co-authors
- Mahmut Bayık (7 shared papers)Işık Kaygusuz (6 shared papers)Stephanie J. Lee (3 shared papers)Nicola Polverelli (1 shared paper)Peter Langmuir (3 shared papers)Sebastian Giebel (3 shared papers)Ronjon Chakraverty (3 shared papers)Jan Moritz Middeke (3 shared papers)
- Journals
- Blood (3 papers)Leukemia Research (1 paper)Apmis (1 paper)Cancer Medicine (1 paper)Journal of the European Academy of Dermatology and Venereology (1 paper)
- Partner nations
- TürkiyeJapanUnited Arab Emirates
In The Last Decade
Ant Uzay
18 papers receiving 429 citations
Ant Uzay's Hit Papers
Peers
Comparison fields: 5 of 51
- Hematology 254
- Genetics 92
- Transplantation 20
- Pathology and Forensic Medicine 95
- Oncology 126
Countries citing papers authored by Ant Uzay
This map shows the geographic impact of Ant Uzay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ant Uzay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ant Uzay more than expected).
Fields of papers citing papers by Ant Uzay
This network shows the impact of papers produced by Ant Uzay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ant Uzay. The network helps show where Ant Uzay may publish in the future.
Co-authors
The 25 scholars most cited alongside Ant Uzay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease Hit paper breakdown → | 2021 | 271 |
| 2 | 2009 | 53 | |
| 3 | 2009 | 39 | |
| 4 | Synchronous renal cell carcinoma and multiple myeloma: report of two cases and review of the literature. | 2010 | 10 |
| 5 | 2015 | 9 | |
| 6 | 2022 | 8 | |
| 7 | 2011 | 8 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 5 | |
| 10 | 2018 | 4 | |
| 11 | 2022 | 4 | |
| 12 | 2012 | 4 | |
| 13 | 2018 | 3 | |
| 14 | 2018 | 2 | |
| 15 | 2012 | 2 | |
| 16 | 2023 | 2 | |
| 17 | 2024 | 1 | |
| 18 | 2020 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2020 | 0 |
About Ant Uzay
Ant Uzay is a scholar working on Hematology, Pathology and Forensic Medicine, Oncology, Genetics and Immunology, having authored 21 papers that have together received 433 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Viral-associated cancers and disorders (2 papers), CAR-T cell therapy research (2 papers) and Platelet Disorders and Treatments (2 papers). The work is most often cited by research in Hematology (254 citations), Genetics (92 citations), Transplantation (20 citations), Pathology and Forensic Medicine (95 citations) and Oncology (126 citations). Ant Uzay has collaborated with scholars based in Türkiye, Japan and United Arab Emirates. Frequent co-authors include Mahmut Bayık, Işık Kaygusuz, Stephanie J. Lee, Nicola Polverelli, Peter Langmuir, Sebastian Giebel, Ronjon Chakraverty, Jan Moritz Middeke, Franco Locatelli and Takanori Teshima. Their work appears in journals such as Blood, Leukemia Research, Apmis, Cancer Medicine and Journal of the European Academy of Dermatology and Venereology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.